6 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Authorisation status
Authorised Remove Authorised filter
Medicine type
Additional monitoring Remove Additional monitoring filter
Generic Remove Generic filter
Categories
Human Remove Human filter
Patient safety
Yes Remove Yes filter
-
List item
Human medicine European public assessment report (EPAR): Xeljanz
tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013,
, 
, Revision: 9, Authorised, Last updated: 06/03/2020
-
List item
Human medicine European public assessment report (EPAR): Lemtrada
alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013,, , Revision: 9, Authorised, Last updated: 29/01/2020
-
List item
Human medicine European public assessment report (EPAR): Xarelto
rivaroxaban, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 30/09/2008,, , Revision: 32, Authorised, Last updated: 17/01/2020
-
List item
Human medicine European public assessment report (EPAR): Xofigo
radium Ra223 dichloride, Prostatic Neoplasms
Date of authorisation: 13/11/2013,, , Revision: 10, Authorised, Last updated: 10/01/2020
-
List item
Human medicine European public assessment report (EPAR): Gilenya
fingolimod hydrochloride , Multiple Sclerosis
Date of authorisation: 17/03/2011,, , Revision: 24, Authorised, Last updated: 20/12/2019
-
List item
Human medicine European public assessment report (EPAR): Juluca
dolutegravir sodium, rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018,, , Revision: 1, Authorised, Last updated: 11/02/2019